Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q88131866)
Watch
English
Hepatitis B virus infection
scientific article published on 18 June 2014
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
title
Hepatitis B virus infection
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
main subject
Hepatitis B virus
1 reference
based on heuristic
inferred from title
hepatitis B
1 reference
based on heuristic
inferred from title
author name string
Christian Trépo
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
Henry L Y Chan
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
Anna Lok
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
language of work or name
English
0 references
publication date
18 June 2014
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
volume
384
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
issue
9959
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
page(s)
2053-2063
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
cites work
Hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rocks along the road to the control of HBV and HCC.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiology of hepatitis B and C viruses: a global overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The increasing burden of imported chronic hepatitis B--United States, 1974-2008.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vertical Transmission of Hepatitis B Antigen in Taiwan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiviral therapy for chronic hepatitis B in pregnancy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B infection in adolescents who received primary infantile vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Minimization of hepatitis B infection by a 25-year universal vaccination program
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The prevalence of hepatitis B virus infection in the United States in the era of vaccination
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevalence of hepatitis B virus infection in The Netherlands in 1996 and 2007.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Should Europe have a universal hepatitis B vaccination programme?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Occult hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus reactivation associated with anti-neoplastic therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naïve, e antigen-positive patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The host-pathogen interaction during HBV infection: immunological controversies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New insight in the pathobiology of hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stealth and cunning: hepatitis B and hepatitis C viruses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune effectors required for hepatitis B virus clearance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Restored Function of HBV-Specific T Cells After Long-term Effective Therapy With Nucleos(t)ide Analogues
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Targeting innate immunity: a new step in the development of combination therapy for chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular genetics of HBV infection.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical implications of hepatitis B virus genotype: Recent advances.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B e antigen and the risk of hepatocellular carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Noninvasive methods to assess liver disease in patients with hepatitis B or C.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chronic hepatitis B: update 2009
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatitis B: our practice and how it relates to the guidelines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effectiveness of hepatitis B treatment in clinical practice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New perspectives in the therapy of chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Response-guided peginterferon therapy in hepatitis B e antigen-positive chronic hepatitis B using serum hepatitis B surface antigen levels
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IL28B polymorphisms predict interferon-related hepatitis B surface antigen seroclearance in genotype D hepatitis B e antigen-negative patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis B
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of HBeAg loss after lamivudine treatment for chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Histological outcome during long-term lamivudine therapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamivudine for patients with chronic hepatitis B and advanced liver disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of hepatocellular carcinoma: An update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EASL clinical practice guidelines: Management of chronic hepatitis B virus infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The clinical significance of persistently normal ALT in chronic hepatitis B infection
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2814%2960220-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(14)60220-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
PubMed publication ID
24954675
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24954675
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24954675%20AND%20SRC:MED&resulttype=core&format=json
retrieved
21 March 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
